MRF Board Chair Pays It Forward with the Congressionally Directed Medical Research Program

Since his initial diagnosis in December 2013, MRF Board Chair and stage 4 melanoma survivor Doug Brodman has helped others understand the value of education, research, and advocacy for the disease and the importance of developing new, more effective treatments. In addition to his service on our Board of Directors, Doug volunteers as a patient advocate on the Department of Defense Congressionally Directed Medical Research Program.

Learn more about his journey from stage 4 metastatic melanoma to No Evidence of Disease and his work to contribute the patient perspective to federal research funding decisions on the CDMRP blog.